According to Genscript Biotech
's latest financial reports the company has a price-to-book ratio of 3.52.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 7.59 | -10.76% |
2021-12-31 | 8.51 | 144.97% |
2020-12-31 | 3.47 | -69.72% |
2019-12-31 | 11.5 | 128.54% |
2018-12-31 | 5.02 | -73.99% |
2017-12-31 | 19.3 | 345.69% |
2016-12-31 | 4.33 | 137.05% |
2015-12-31 | 1.83 |